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The N-end rule relates the in vivo half-life of a protein
to the identity of its N-terminal residue. In both fungi
and mammals, the tertiary destabilizing N-terminal res-
idues asparagine and glutamine function through their
conversion, by enzymatic deamidation, into the second-
ary destabilizing residues aspartate and glutamate,
whose destabilizing activity requires their enzymatic
conjugation to arginine, one of the primary destabiliz-
ing residues. We report the isolation and analysis of a
mouse cDNA and the corresponding gene (termed
Ntan1) that encode a 310-residue amidohydrolase
(termed NtN-amidase) specific for N-terminal aspara-
gine. The ;17-kilobase pair Ntan1 gene is located in the
proximal region of mouse chromosome 16 and contains
10 exons ranging from 54 to 177 base pairs in length. The
;1.4-kilobase pairNtan1mRNA is expressed in all of the
tested mouse tissues and cell lines and is down-regu-
lated upon the conversion of myoblasts into myotubes.
The Ntan1 promoter is located ;500 base pairs up-
stream of the Ntan1 start codon. The deduced amino
acid sequence of mouse NtN-amidase is 88% identical to
the sequence of its porcine counterpart, but bears no
significant similarity to the sequence of the NTA1-en-
coded N-terminal amidohydrolase of the yeast Saccha-
romyces cerevisiae, which can deamidate either N-termi-
nal asparagine or glutamine. The expression of mouse
NtN-amidase in S. cerevisiae nta1D was used to verify
that NtN-amidase retains its asparagine selectivity in
vivo and can implement the asparagine-specific subset
of the N-end rule. Further dissection of mouse Ntan1,
including its null phenotype analysis, should illuminate
the functions of the N-end rule, most of which are still
unknown.
Features of proteins that confer metabolic instability are
called degradation signals, or degrons (1). The essential com-
ponent of one degradation signal, termed the N-degron, is a
destabilizing N-terminal residue of a protein (2). A set of N-
degrons containing different destabilizing residues yields a
rule, termed the N-end rule, that relates the in vivo half-life1 of
a protein to the identity of its N-terminal residue (reviewed in
Refs. 3 and 4). The N-end rule pathway has been found in all
species examined, including the eubacterium Escherichia coli
(5), the yeast Saccharomyces cerevisiae (6), and mammalian
cells (7, 8). The N-end rules of these organisms are similar but
distinct (4).
The understanding of the functions of the N-end rule is
sketchy. In particular, the N-end rule pathway has been shown
to be required for the import of peptides in S. cerevisiae (9); it
may also be involved in the control of signal transduction and
cell differentiation (10, 11). Physiological substrates of the N-
end rule pathway include Sindbis virus RNA polymerase (12)
and yeast Ga, the GPA1-encoded a subunit of the heterotrim-
eric G protein (13).
In eukaryotes, the N-degron comprises at least two determi-
nants: a destabilizing N-terminal residue and an internal ly-
sine (or lysines) of a substrate (6, 14–16). The Lys residue is the
site of formation of a multiubiquitin chain (17–20). Ubiquitin
(Ub)2 is a 76-residue protein whose covalent conjugation to
other proteins is involved, directly or by way of regulation, in a
multitude of processes, including cell growth and differentia-
tion, signal transduction, DNA repair, and the transport of
substances across membranes. In many of these processes, Ub
acts through routes that involve protein degradation (reviewed
in Refs. 4 and 21–26).
The N-end rule is organized hierarchically. In eukaryotes
such as the yeast S. cerevisiae, Asn and Gln are tertiary desta-
bilizing N-terminal residues (denoted as N-dt) in that they
function through their conversion, by N-terminal amidohydro-
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lase (Nt-amidase), into the secondary destabilizing N-terminal
residues Asp and Glu (denoted as N-ds), whose destabilizing
activity requires their conjugation, by Arg-tRNA-protein trans-
ferase (R-transferase), to Arg, one of the primary destabilizing
N-terminal residues (denoted as N-dp) (6, 27, 28). The N-dp
residues are bound directly by N-recognin (also called E3), the
recognition component of the N-end rule pathway (4). In S.
cerevisiae, N-recognin is a 225-kDa protein (encoded by UBR1)
that selects potential N-end rule substrates by binding to their
N-dp residue Phe, Leu, Trp, Tyr, Ile, Arg, Lys, or His (29–31).
This binding is followed by the formation of a substrate-linked
multi-Ub chain in a reaction mediated by the Ub-conjugating
enzyme (E2) Ubc2p, one of at least 11 distinct E2 enzymes in S.
cerevisiae (31, 32). The substrate is then processively degraded
by the 26 S proteasome, an ;2-MDa, ATP-dependent, multi-
subunit protease (33–38). The four “upstream” components of
the S. cerevisiae N-end rule pathway (Nta1p (Nt-amidase),
Ate1p (R-transferase), Ubc2p (a Ub-conjugating enzyme), and
Ubr1p (N-recognin)) are physically associated in a targeting
complex (27, 31).3
The NTA1-encoded Nt-amidase of S. cerevisiae can deami-
date N-terminal Asn or Gln (3, 27). Stewart et al. (39, 40)
reported the purification of a porcine Nt-amidase and the clon-
ing of its ;1.3-kb cDNA. In contrast to the yeast Nt-amidase
(Nta1p), this Nt-amidase, termed NtN-amidase, can deamidate
N-terminal Asn but not Gln. Described below is the isolation
and characterization of Ntan1, an ;17-kb gene4 that encodes a
mouse homolog of the porcine enzyme, termed NtN-amidase
(the superscript “N” and the second “N” in the gene’s name
refer to the Asn specificity of this Nt-amidase).
Both Asn and Gln are destabilizing residues in the mamma-
lian N-end rule (7, 8). Furthermore, both N-terminal Asn and
Gln of test proteins are deamidated in mammalian cell extracts
(7).5 Since NtN-amidase deamidates N-terminal Asn but not
Gln, there must exist yet another mammalian Nt-amidase,
which can deamidate N-terminal Gln. The resulting bifurcation
in the structure of the mammalian N-end rule is illustrated in
Fig. 1. Ntan1 is the first cloned mammalian gene whose func-
tion appears to be confined to the N-end rule pathway.
EXPERIMENTAL PROCEDURES
Bacterial and Yeast Strains and Genetic Techniques—The E. coli
strains MC1061, DH5a, and JM101 were grown in Luria broth contain-
ing relevant antibiotics and were transformed using the calcium chlo-
ride method (41). S. cerevisiae was grown on rich (YPD) or synthetic
medium containing 2% glucose (SD medium) or 2% galactose (SG me-
dium) (42). Unless stated otherwise, the transformation of S. cerevisiae
was carried out as described (43). The S. cerevisiae strains were
YPH500 (MATa ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-
D1) (44) and SGY4, an nta1-D2::LEU2 derivative of YPH500. SGY4 was
constructed by transforming YPH500 (using the procedure of Ref. 45)
with an XhoI-XbaI fragment of the plasmid pSG8 that bore the
nta1-D2::LEU2 deletion/disruption allele and selecting for Leu1 cells.
Southern hybridization analysis of Leu1 transformants, using restric-
tion endonuclease cuts diagnostic of the transplacement (46), was used
to verify the predicted structure of the integrated nta1-D2::LEU2 allele.
The plasmid pSG8 was derived from a plasmid (based on pRS316 (41))
that contained S. cerevisiae NTA1 between XhoI and XbaI sites (27).
Replacement of the SpeI-EcoRI fragment of the NTA1 ORF with LEU2
yielded pSG8.
b-Galactosidase Assays—Colony assays for E. coli b-galactosidase
(bgal) in S. cerevisiae were carried out by overlaying yeast colonies on
SG plates with 0.5% agarose containing 0.1% SDS, 4% dimethylform-
amide, and a 0.1 mg/ml concentration of the chromogenic bgal substrate
5-bromo-4-chloro-3-indolyl b-D-galactoside, followed by incubation for a
few hours at 37 °C and examination of the colony color (white to blue,
depending on the level of bgal). Quantitative assays for bgal activity
were carried out with S. cerevisiae whole cell extracts using another
bgal substrate, chlorophenol red b-D-galactopyranoside. Cells in a 1-ml
culture (A600 ; 1) were pelleted by centrifugation and resuspended in 1
ml of buffer K (1 mM MgCl2, 0.1 M potassium phosphate, pH 7.0). After
determining the A600 of the suspension, 50- or 100-ml samples were
diluted to 1 ml with buffer K. 0.1% SDS (20 ml) and CHCl3 (50 ml) were
then added; the suspension was vortexed for 20 s and incubated for 15
min at 30 °C, followed by the addition of 20 ml of chlorophenol red
b-D-galactopyranoside (34 mg/ml in buffer K) and further incubation at
30 °C. The A574 of a sample was measured at different incubation times
(after clarification by a brief centrifugation in a microcentrifuge). The
chlorophenol red b-D-galactopyranoside units (UCPRG) of bgal activity
were calculated as follows: UCPRG 5 A574/tzvzA600, where t and v are the
time of incubation (min) and the sample volume (ml), respectively.
Mammalian Cell Lines—The mouse Friend erythroleukemia cell line
MEL-C19 was provided by Dr. L. A. Brents (NCI, National Institutes of
Health, Bethesda, MD). The mouse lymphoma (EL4.IL-2) and myoblast
(C2C12) cell lines were purchased from the American Type Culture
Collection (Rockville, MD). MEL and EL4 cells were grown in Dulbec-
co’s modified Eagle’s/Ham’s F-12 medium (Mediatech, Herndon, VA).
C2C12 cells were grown in Dulbecco’s modified Eagle’s medium plus 4.5
g/liter glucose (Mediatech). All media were supplemented with 10%
fetal bovine serum, glutamine, penicillin, streptomycin, and pyruvate
(47). MEL cells were induced to differentiate in RPMI 1640 medium
(Mediatech) containing 10% fetal bovine serum by adding N,N9-hexa-
methylenebisacetamide to a final concentration of 3 mM and incubating
a culture for another 5 days. C2C12 cells were induced to differentiate by
replacing fetal bovine serum with 10% horse serum and incubating a
confluent culture for 4–5 days.
Cloning of the Mouse Ntan1 cDNA—Stewart et al. (39, 40) have
purified an amidohydrolase, termed NtN-amidase, from porcine liver
that is specific for N-terminal Asn in polypeptides; they also determined
the N-terminal sequence of porcine NtN-amidase (peptide 1) and several
sequences of internal peptides (including peptide 2) produced by frag-
mentation with cyanogen bromide (see Fig. 2A). Stewart et al. (40)
employed “reverse-translated” oligonucleotides corresponding to the
sequences of peptides 1 and 2 to isolate a 632-bp porcine cDNA frag-
ment whose 59- and 39-regions encoded the sequences of peptides 1 and
2, respectively.
To clone a mouse cDNA (termed Ntan1 cDNA) that encoded a hom-
olog of the porcine NtN-amidase, we used cDNA libraries (CLONTECH,
Palo Alto, CA) prepared from mouse liver (in lgt11) and MEL-C19 cells
(in lgt10). A low-stringency hybridization screening (carried out as
recommended by CLONTECH) of the mouse liver cDNA library utilized
the above 632-bp porcine cDNA fragment (at the time, only that frag-
ment of the subsequently cloned porcine Ntan1 cDNA had been isolated
by Stewart et al. (40)). A positive clone contained a 1560-bp mouse DNA
insert; a 114-bp region of this insert was 85% identical to the nucleotide
sequence of a region of the porcine Ntan1 mRNA. This and other
evidence (see “Results”) suggested that the 1560-bp mouse DNA frag-
ment was derived from an unspliced or partially spliced Ntan1
pre-mRNA.
Since a Northern hybridization with the 1560-bp fragment as a probe
suggested that the abundance of mouse Ntan1mRNA in MEL cells was
significantly higher than in the liver, the 1560-bp fragment was used to
screen a lgt10-based cDNA library prepared from MEL cells. Two
positive clones (out of ;5 3 106 clones screened) containing mouse
cDNA inserts of 1030 and 605 bp were obtained. The amino acid se-
quence encoded by the larger insert (which encompassed most of the
605-bp insert) was 83% identical to the deduced sequence of porcine
NtN-amidase (40); the region of similarity began 33 nucleotides down-
stream of the ATG start codon in the porcine Ntan1 ORF. In the 605-bp
mouse cDNA insert, the TAA stop codon of the putative mouse Ntan1
ORF was followed by 157 nucleotides of untranslated region linked to a
poly(A) tract. The 1030-bp mouse cDNA insert ended 9 bp upstream of
the poly(A) addition site.
On the assumption that the 1030-bp mouse cDNA insert lacked a
sequence corresponding to the 59-coding region of the mouse Ntan1
mRNA, we employed the 59-RACE-PCR technique (48, 49) to amplify
the missing region, using an oligonucleotide primer specific for the
1030-bp clone and a primer complementary to an in vitro produced
59-oligo(dC) tract. Specifically, poly(A)1 mRNA was isolated from ;4 3
108 MEL cells using the Fast Track mRNA isolation kit (Invitrogen, San
Diego, CA) and dissolved in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0, to an
3 M. Ghislain, A. Webster, and A. Varshavsky, unpublished data.
4 The names of mouse genes are in italics, with the first letter upper-
case. The names of the corresponding mouse proteins are Roman, all
upper-case. The names of S. cerevisiae genes are in italics, all upper-
case. The names of the corresponding yeast proteins are Roman, with
the first letter upper-case and an extra lower-case “p” at the end (86).
5 S. Grigoryev and A. Varshavsky, unpublished data.
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A260 of 5. 1.5 ml of this sample were diluted with 12 ml of diethyl
pyrocarbonate-treated water, incubated at 70 °C for 5 min, and cooled
on ice. To this sample were added 20 pmol of a primer corresponding to
the antisense strand of the mouse Ntan1 ORF between nucleotides
1700 and 1725 (GenBankTM/EMBL accession number U57692), 2 ml of
10 3 PCR buffer (Perkin-Elmer), 2 ml of 0.1 M dithiothreitol, 1 ml of 10
mM dNTPs, 1 ml of 25 mM MgCl2, and 1 ml of bovine serum albumin (2
mg/ml). The sample was incubated at 42 °C for 2 min, followed by the
addition of 1 ml of Superscript II reverse transcriptase (Life Technolo-
gies, Inc.) and incubation at 42 °C for another 40 min. The temperature
was increased to 55 °C, followed by the addition of 1 ml of RNase H (Life
Technologies, Inc.; 2 units/ml) and incubation for 20 min. The resulting
cDNA products were purified with Glass Max (Life Technologies, Inc.)
using three standard washes plus a wash with cold 70% ethanol and
were eluted with 50 ml of water.
To produce a cDNA-linked 59-oligo(dC) extension, 5 ml of purified
cDNA were diluted with 11.5 ml of water; incubated at 70 °C for 5 min;
cooled on ice; and then mixed with 1 ml of 10 3 PCR buffer (to a final
concentration of 0.53), 1 ml of 25 mM MgCl2, 0.5 ml of bovine serum
albumin (2 mg/ml), 0.5 ml of 10 mM dCTP, and 0.25 ml of terminal
transferase (Boehringer Mannheim). After incubation at 37 °C for 5
min, the enzyme was inactivated by heating the sample at 65 °C for 10
min. The first round of RACE-PCR amplification was carried out in a
100-ml sample containing 10 ml of 10 3 PCR buffer, 2.5 mM MgCl2, 5 ml
of cDNA linked to oligo(dC), 20 pmol of a primer corresponding to the
antisense strand of the Ntan1 ORF between nucleotides 1283 and
1310 (GenBankTM/EMBL accession number U57692), and 20 pmol of
G-anchor primer (59-AGGCCACGCGTCGACTAGTAC(G)17-39). The
sample was incubated at 94 °C for 5 min and then at 57 °C for 8 min,
followed by the addition of AmpliTaq DNA polymerase (Perkin-Elmer)
and incubation at 72 °C for 8 min to produce the strand complementary
to cDNA. Thereafter, 35 cycles of a three-step PCR amplification were
carried out. Each step involved consecutive incubations for 30 s at
94 °C, for 1 min at 57 °C, and for 2 min at 72 °C. 2 ml of the first-round
PCR product were used for the second round of PCR that utilized, in the
same total volume, 0.4 nmol of G-adapter primer (same as the G-anchor
primer but lacking G17) and 0.4 nmol of a primer corresponding to the
antisense strand of the Ntan1 ORF between nucleotides 1232 and 1259.
The PCR-produced DNA fragments were inserted into pCRII (In-
vitrogen). Four of the resulting clones were sequenced; all of them
contained an ATG codon preceded by one and the same 34-bp sequence
and followed by a region encoding an amino acid sequence similar to the
directly determined N-terminal sequence of the purified porcine NtN-
amidase (40). An in-frame stop codon 6 bp upstream of the above ATG
codon suggested that the latter was indeed the in vivo start codon of the
Ntan1 ORF. To construct the full-length Ntan1 cDNA, PCR was carried
out using the above 1030-bp Ntan1 cDNA fragment as a template, the
primer 59-GTAGGTACCGCCTTTGCCAAAAATAAGATTTTATTTTG-
-39 (which was complementary to the 39-end of Ntan1 cDNA and con-
tained a KpnI site), and the primer 59-ATCCTCGAGCATATGCCACT-
GCTGGTGGATGGGCAGCGCGTCCGTCTGCCACGGTCCGC-39 (which
was complementary to the 59-end of the 1030-bp fragment and con-
tained an XhoI site as well as the RACE-PCR-derived 59-proximal re-
gion of Ntan1 cDNA that was absent from the 1030-bp fragment). The
PCR product was digested with KpnI and XhoI; the resulting fragment
was inserted into KpnI/XhoI-cut lTRP vector (a gift from Dr. S. Elledge,
Baylor College of Medicine, Houston, TX), a variant of the vector lYES
(50) that contained S. cerevisiae TRP1 (instead of URA3) as a selectable
marker. The resulting plasmid, pSG61, was used to express the mouse
NTAN1 protein in S. cerevisiae from the PGAL1 promoter.
Cloning and Sequencing of the Mouse Ntan1 Gene—A genomic DNA
library produced from mouse embryonic stem cells (strain C129) and
carried in the P1 phage (51) was used. Screening of the library (164,000
P1 clones arranged in 400 pools) was carried out by Genome Systems
Inc. (St. Louis, MO) as a custom service, using PCR and synthetic
primers derived from the sequence of the mouse Ntan1 cDNA (nucleo-
tides 1641 to 1663 and nucleotides 1730 to 1752 (GenBankTM/EMBL
accession number U57692)) (see Fig. 2B). Four positive clones were
identified; one of them (clone 1798) was used for further analysis. To
amplify and isolate a P1 plasmid containing the insert 1798, 0.3 ml of
an overnight E. coliNS3529 culture bearing the plasmid was inoculated
into 30 ml of Luria broth containing kanamycin at 25 mg/ml. Following
a 30-min incubation at 37 °C in a rotary shaker, isopropylthiogalacto-
side was added to a final concentration of 1 mM (to induce the lytic
operon of P1), and the culture was incubated at 37 °C until saturation
(;5 h). The P1 plasmid was isolated using the alkaline lysis method
(41). The plasmid was digested with various restriction endonucleases;
the resulting fragments were subcloned into pUC18 (41) or Bluescript II
SK(1) (Stratagene, La Jolla, CA) and propagated in E. coli DH5a.
Genomic DNA inserts containing sequences of Ntan1 cDNA were iden-
tified by colony hybridization using the Ntan1 cDNA insert of pSG61
(see above) as a probe. The regions of Ntan1 that encompassed exons
I–X and the regions of introns adjacent to exons were sequenced using
the chain termination method (41) and exon-specific primers. The phys-
ical map of the Ntan1 locus (see Fig. 3) was produced initially by
restriction mapping of Ntan1-specific genomic DNA fragments and by
PCR-based analyses of DNA that spanned the borders of sequenced
regions. Subsequently, the entire ;17-kb Ntan1 gene was sequenced
using a similar strategy: identifying a set of restriction fragments of P1
clone 1798 that encompassed the Ntan1 locus, subcloning these frag-
ments to a size of ;1.5 kb into Bluescript II SK(1), and sequencing the
inserts from both ends. The remaining regions were sequenced using
primers specific for the junctions to already sequenced fragments. Most
(.75%) of the Ntan1 fragments were sequenced on both strands. These
nucleotide sequences have been submitted to the GenBankTM/EMBL
Data Bank with accession numbers U57692 (Ntan1 cDNA) and U57691
(Ntan1 genomic DNA).
Cloning of Mouse cDNA Encoding the E214K Ub-conjugating En-
zyme—We screened the lgt10-based cDNA library prepared from MEL
cells (see above) with the rabbit E214K cDNA (a gift from Dr. S. Wing)
(52) as a probe. In this library, the E214K probe detected an ;30-fold
higher number of clones than the Ntan1 probe, consistent with a lower
in vivo level of Ntan1 mRNA in comparison with E214K mRNA (see
“Results”). All four of the analyzed mouse E214K cDNAs contained
identical sequences encompassing the E214K ORF (GenBank
TM acces-
sion number U57690), which was 93% identical to the rabbit E214K ORF
and which encoded an amino acid sequence 100% identical to that of
rabbit E214K. However, while three of the mouse E214K cDNAs con-
tained a poly(A) sequence 174 bp downstream of the E214K ORF, in the
fourth cDNA, the poly(A) sequence was located 500 bp farther down-
stream (data not shown), consistent with the presence of two E214K
mRNA species in the Northern hybridization patterns (see “Results”).
59-Mapping of Ntan1 mRNA—Total cytoplasmic RNA was isolated
from mouse MEL-C19 cells as described (41). The primer extension
mapping was carried out as described (41) using 50 mg of RNA/assay.
The Superscript II polymerase (Life Technologies, Inc.) was used for the
reverse transcription step, which employed the following synthetic
primers: nucleotides 985-1014 and 1485–1511, corresponding to the
antisense DNA strand of Ntan1 (see Fig. 2B). Reaction products were
analyzed by polyacrylamide gel electrophoresis on a 9% sequencing gel.
Chromosome Mapping of the Mouse Ntan1 Gene—The chromosomal
position of Ntan1 was determined using the interspecific backcross
analysis. Interspecific backcross progeny were generated by mating
(C57BL/6J 3 Mus spretus)F1 females and C57BL/6J males as described
(53). A total of 205 N2 mice were used to map Ntan1. DNA isolation,
digestion with restriction endonucleases, gel electrophoresis, and
Southern hybridization were performed essentially as described (54).
All blots were prepared with Hybond-N1 nylon membranes (Amersham
Corp.). The probe, an ;2.3-kb EcoRI fragment of mouse genomic DNA
that encompasses exons II–IV of Ntan1, was labeled with [a-32P]dCTP
using a nick translation labeling kit (Boehringer Mannheim); washing
was carried out to a final stringency of 0.1 3 SSCP, 0.1% SDS at 65 °C.
An ;15-kb fragment and an ;4-kb fragment were detected with this
probe in HindIII-digested C57BL/6J DNA andM. spretus DNA, respec-
tively. The presence or absence of the ;4-kbM. spretus-specific HindIII
fragment was followed in DNA of backcross mice.
A description of the probes and restriction fragment length polymor-
phisms for the loci linked to Ntan1, including the loci encoding prota-
mine-1 (Prm1), CCAAT/enhancer-binding protein-d (Cebpd), and the
immunoglobulin l chain (Igl), has been reported (55). Recombination
distances were calculated as described (56) using the program SPRE-
TUS MADNESS. Gene order was determined by minimizing the num-
ber of recombination events required to explain the allele distribution
patterns.
Southern and Northern Hybridizations—For Southern hybridiza-
tion, DNA was isolated from mouse liver, digested with restriction
endonucleases, fractionated on 1% agarose gels, and blotted onto Hy-
bond-N1 membranes as described (41). Prehybridization was carried
out at 42 °C for 5 h in a buffer containing 2 3 Denhardt’s solution, 1 M
NaCl, 0.5% SDS, 1 mM EDTA, 50 mM Tris-HCl, pH 7.5, and 0.1 mg/ml
sheared denatured calf thymus DNA. Hybridization was performed at
37 °C for 40 h in hybridization buffer (0.5 3 Denhardt’s solution, 30%
formamide, 1% SDS, 5 mM EDTA, 1 M NaCl, 50 mM sodium phosphate,
pH 7.2, and 0.1 mg/ml sheared denatured calf thymus DNA). The probe
DNA was labeled to ;109 cpm/mg using [32P]dCTP and the Random
Primer labeling kit (DuPont NEN). The final concentration of labeled,
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heat-denatured probe DNA was ;5 ng/ml. After hybridization, the
membranes were washed under low-stringency conditions (2 h at 25 °C
in 0.4 M NaCl, 1% SDS, 5 mM EDTA, and 5 mM sodium phosphate, pH
7.2). For washes of increasing stringency, carried out with shaking for
30 min, the concentration of NaCl was decreased in 0.1 M increments; at
0 M NaCl, the temperature of washes was increased, in 10 °C incre-
ments, to 65 °C.
For Northern hybridization, the poly(A)1 RNA was isolated from
mouse MEL-C19 cells, mouse lymphoma EL4.IL-2 cells, and mouse
C2C12 myoblasts using the Fast Track mRNA isolation kit (Version 3.5).
The mouse skeletal muscle poly(A)1 RNA was purchased from CLON-
TECH. RNA was fractionated by electrophoresis on 1% agarose-form-
aldehyde gels and blotted onto Hybond-N1 membranes as described
(41). Northern hybridization was carried out as recommended by
CLONTECH (protocol c, for hybridization with DNA probes). The
probes (labeled with 32P as described above) were mouse b-actin cDNA
(CLONTECH) and DNA inserts of the plasmids pSG61 (mouse Ntan1
cDNA; see above), pSG72 (mouse E214K cDNA; see above), and pSG76
(mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA).
The GAPDH cDNA was produced using reverse transcription-PCR (41),
the oligo(dT)-primed MEL-C19 cDNA library (see above), and the
GAPDH-specific primers 59-ATGGTGAAGGTCGGTGTGAACGGA-39
and 59-TTACTCCTTGGAGGCCATGTAGGC-39, derived from the se-
quence of GAPDH cDNA (57).
X-DHFR Test Proteins—ORFs encoding Ub-X-dihydrofolate reduc-
tase fusion proteins (Ub-X-DHFR proteins) (construct I of Ref. 6; X 5
Asn, Asp, or Gln) were used to replace ORFs encoding Ub-X-bgal in
pKKUB-X-bgal plasmids (5). The resulting plasmids, pSG4, pSG41, and
pSG44, expressed Ub-Asn-DHFR, Ub-Asp-DHFR, and Ub-Gln-DHFR,
respectively, from the Ptrc promoter. E. coli JM101 was transformed
with one of these plasmids and also with pJT184, which expressed
Ubp1p, a Ub-specific protease of S. cerevisiae (5). A 50-ml culture was
grown at 37 °C to an A600 of ;0.9 in Luria broth plus ampicillin (40
mg/ml) and chloramphenicol (20 mg/ml). Unless stated otherwise, all
subsequent procedures were carried at 4 °C. The culture was chilled on
ice for 15 min; centrifuged at 3000 3 g for 5 min; washed twice with M9
medium (41); and resuspended in 50 ml of M9 medium supplemented
with glucose (0.2%), thiamine (2 mg/ml), ampicillin (40 mg/ml), 1 mM
isopropylthiogalactoside, and methionine assay medium (Difco). The
suspension was shaken for 1 h at 37 °C, followed by the addition of 1
mCi of Tran35S-label (ICN, Costa Mesa, CA) and further incubation for
1 h at 37 °C. Unlabeled L-methionine was then added to 1 mM, and the
shaking was continued for another 10 min. The cells were harvested by
centrifugation; washed twice with M9 medium; and resuspended in 0.5
ml of 25% (w/v) sucrose, 50 mM Tris-HCl, pH 8.0. Freshly prepared egg
white lysozyme (0.1 ml of a 10 mg/ml solution in 0.25 M Tris-HCl, pH
8.0) was then added, and the suspension was incubated for 5 min at
0 °C, followed by the addition of 0.1 ml of 0.5 M EDTA, pH 8.0, and a
5-min incubation at 0 °C. The suspension was transferred to a centri-
fuge tube containing 1 ml of 65 mM EDTA, 50 mM Tris-HCl, pH 8.0, and
protease inhibitors (25 mg/ml each antipain, chymostatin, leupeptin,
pepstatin, and aprotinin; Sigma). Triton X-100 (10 ml of a 10% (v/v)
solution) was then added and dispersed by pipetting. The lysate was
centrifuged at 40,000 3 g for 30 min in a TL-100 ultracentrifuge
(Beckman Instruments). The supernatant containing 35S-X-DHFR (the
Ub moiety of Ub-X-DHFR was removed in vivo by the Ubp1p protease)
was frozen in liquid N2 and stored at 280 °C. X-DHFR (X 5 Asn, Asp,
or Glu) was purified on a methotrexate affinity column (Pierce; 0.5-ml
bed volume) that had been equilibrated in 50 ml of 50 mM Tris-HCl, pH
7.2. The thawed 35S-supernatant was clarified by centrifugation at
12,000 3 g for 1 min and applied to the column, which was then washed
with 10 ml of 1 M KCl, 20 mM Tris-HCl, pH 8.0. X-DHFR was eluted
with 2 mM folic acid, 50 mM Tris-HCl, pH 8.0. The elution buffer was
applied in 1-ml samples, and 1-ml fractions were collected. Pooled
fractions containing the peak of eluted 35S were dialyzed for 20 h
against two changes of 50% glycerol, 1 mMMgCl2, 0.1 mM EDTA, and 40
mM HEPES, pH 7.5, and stored at 220 °C. 35S-X-DHFR proteins were
examined by SDS-polyacrylamide gel electrophoresis and fluorography
and found to be .95% pure.
Isoelectric Focusing Assay for Amidase Activity—30 ml of an S. cer-
evisiae culture (A600 ; 1) were collected; washed once with 40 ml of
water; pelleted at 3000 3 g; washed once with 40 ml of buffer A (125 mM
KCl, 15 mM MgCl2, and 70 mM Tris-HCl, pH 8.0); and resuspended in 1
ml of buffer A containing 1 mM dithiothreitol, 0.2 mM phenylmethylsul-
fonyl fluoride, and the above mixture of protease inhibitors. 0.4 ml of
0.5-mm glass beads was added, and the suspension was vortexed at the
maximal setting (three times for 1 min, with 2-min incubations on ice in
between). The lysate was centrifuged at 12,000 3 g for 5 min, and the
supernatant was used for the amidase assay either immediately or after
dilution with buffer A containing 1% bovine serum albumin.
In most assays, 5 ml of 35S-X-DHFR (0.5 mg/ml in storage buffer)
were mixed with 20 ml of yeast extract, incubated for 20 min at 30 °C,
and thereafter chilled on ice. Samples (5 ml) were applied onto isoelec-
tric focusing (IEF) polyacrylamide plates, pH 3.5–9.5 (Pharmacia Bio-
tech Inc.), precooled to 10 °C. IEF was carried out for 80 min at 30 watts
in a cooled IEF apparatus (Hoefer Scientific Instruments, San Fran-
cisco, CA). The plates were soaked in 100 ml of 10% CCl3COOH, 5%
5-sulfosalicylic acid; stained with Coomassie Blue to detect IEF mark-
ers (Pharmacia Biotech Inc.); and autoradiographed. 35S in the bands of
more acidic (deamidated) and more basic (initial) X-DHFR species was
quantified using a PhosphorImager (Molecular Dynamics, Inc., Sunny-
vale, CA).
Pulse-Chase Analysis—S. cerevisiae nta1D-carrying plasmids that
expressed specific X-bgal (Ub-X-bgal) test proteins and either mouse
NTAN1 (pSG61; see above) or S. cerevisiae Nta1p (pRB201 (27); a gift
from Dr. R. T. Baker) were labeled with Tran35S-label for 5 min,
followed by a chase in the presence of cycloheximide, preparation of
extracts, immunoprecipitation of X-bgal, SDS-polyacrylamide gel elec-
trophoresis, autoradiography, and quantitation essentially as described
(27–30, 58, 59).
RESULTS
Cloning and Analysis of the Mouse cDNA Encoding NtN-
amidase—Stewart et al. (39) have purified an amidohydrolase,
termed NtN-amidase (also called protein-N-terminal aspara-
gine amidohydrolase), from porcine liver that specifically de-
amidates N-terminal Asn in polypeptides, but does not deami-
date free Asn. Stewart et al. (40) have also determined the
amino acid sequence of several NtN-amidase fragments and
used it to clone an ;1.3-kb porcine cDNA (Ntan1 cDNA) en-
coding this enzyme. To isolate a mouse Ntan1 cDNA, we
screened a lgt11-based mouse liver cDNA library with a por-
cine cDNA-derived probe and low-stringency hybridization (see
“Experimental Procedures”). The initially isolated 1560-bp
mouse DNA insert contained a 114-bp stretch that was 85%
identical to a region of the porcine Ntan1 mRNA; an even
greater similarity between this region and its porcine counter-
part was apparent at the level of deduced amino acid se-
quences. This 114-bp region was flanked by consensus se-
quences for mammalian intron/exon junctions (60), suggesting
that the library’s 1560-bp mouse DNA insert was derived from
an unspliced or partially spliced precursor of Ntan1 mRNA. It
is shown below that the 114-bp region of the 1560-bp insert is
exon IX of the mouse Ntan1 gene.
Northern hybridization with the 1560-bp fragment as a
probe detected an ;1.4-kb mRNA whose relative abundance in
several mouse cell lines, including Friend erythroleukemia
(MEL) cells, was significantly higher than in mouse liver (see
below). Therefore, we screened a cDNA library from mouse
MEL-C19 cells with the 1560-bp DNA fragment as a probe.
This screen yielded a 1030-bp mouse DNA insert containing a
897-bp region that encoded a protein whose deduced amino acid
sequence was 83% identical to the deduced sequence of porcine
NtN-amidase, but lacked a region homologous to the sequence
of the N-terminal 11 residues of the porcine enzyme. The
method of 59-RACE-PCR (see “Experimental Procedures”) was
used to isolate the missing mouse cDNA sequence.
The resulting mouse Ntan1 cDNA clone contained a 930-bp
ORF encoding a 310-residue (35 kDa) NTAN1 protein (NtN-
amidase) with a calculated pI of 6.1, whose deduced amino acid
sequence (Fig. 2A) was 88% identical to the deduced sequence
of porcine NtN-amidase (40). The recently determined (de-
duced) sequence of human NtN-amidase is 92 and 91% identical
to the deduced sequences of mouse and porcine NtN-amidases,
respectively.6 The sequences of these NtN-amidases lack signif-
6 S. Yu, A. E. Stewart, S. M. Arfin, and R. A. Bradshaw, manuscript
in preparation.
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icant similarities to the sequences of other known proteins,
including other amidotransferases. In particular, the sequence
of the 35-kDa mouse NTAN1 protein was dissimilar to the
sequence of the 52-kDa S. cerevisiae amidase (Nt-amidase)
encoded by the NTA1 gene. (In contrast to NtN-amidase, the S.
cerevisiae Nta1p Nt-amidase (a component of the yeast N-end
rule pathway) deamidates N-terminal Asn or Gln (Fig. 1).) The
deduced sequence of mouse NTAN1 (Fig. 2A) lacks motifs re-
sembling membrane-spanning regions, signal sequences, or nu-
clear localization signals. Since NtN-amidase is likely to be a
part of a multiprotein targeting complex analogous to the one
observed in yeast (4), the absence of nuclear localization signal-
like sequences in NTAN1 does not, by itself, preclude the pos-
sibility that NtN-amidase is located in both the cytosol and the
nucleus.
A partially translated 208-bp region that begins at nucleo-
tide 896 of the 930-bp mouse Ntan1 ORF (nucleotide 17031 in
Fig. 2B) and encompasses the Ntan1 mRNA poly(A) addition
site (Fig. 2B) is 98.6% identical to a 206-bp segment within the
39-flanking untranslated region of the mouse Il2 gene that
encodes interleukin-2. The Il2-homologous region ofNtan1 con-
tains the Ntan1 stop codon and the poly(A) addition site (Fig.
2B); neither of these functions is performed by the correspond-
ing sequences of the Il2 locus. The near identity of sequences in
these two regions of the mouse Ntan1 and Il2 loci and the
absence of significant sequence similarities between the corre-
sponding regions of human NTAN1 and IL2 (data not shown)
suggest a recombination event in the mouse lineage that in-
volved Ntan1 and Il2 and that occurred after separation of the
mouse and human lineages.
Cloning and Analysis of the Mouse Ntan1 Gene—A low-
stringency Southern hybridization analysis of the BALB/c
mouse kidney DNA digested with EcoRI, BamHI, or HindIII,
using the 1560-bp fragment containing a putative 114-bp
Ntan1 exon (see above) as a probe, revealed several hybridizing
restriction fragments. A screening of a phage P1-based mouse
genomic DNA library (derived from embryonic stem cells) for
an insert containing the 114-bp Ntan1 exon was carried out
(see “Experimental Procedures”), yielding several P1 clones
bearing ;100-kb mouse DNA inserts. Three of these inserts
were found to contain the entire Ntan1 locus; one of them (P1
clone 1798) was used for nucleotide sequencing and exon
mapping.
The mouse Ntan1 gene was found to span ;17 kb of DNA
and to contain 10 exons whose length ranged from 54 to 177 bp
(GenBankTM/EMBL accession number U57691) (Figs. 2B and
3). The 79-bp exon I, encoding the first 26 residues of NTAN1,
was located in an ;1.7-kb BamHI fragment, which also con-
tained the putative promoter region of Ntan1 and the 59-un-
translated leader sequence (Figs. 2B and 3). The 177-bp exon X
encoded the last 59 residues of NTAN1 and was followed by the
138-bp 39-untranslated region containing the poly(A) addition
site, which was also the boundary of a region homologous to the
locus that encodes interleukin-2 (Figs. 2B and 3).
Among the intron/exon junctions, all of them except those of
introns I and V contained the GT and AG consensus dinucle-
otides characteristic of mammalian nuclear pre-mRNA splice
sites (60, 61). However, intron I contained TG (instead of con-
sensus GT) and AC (instead of consensus AG) at the 59- and
39-splice sites, respectively, while intron V contained CG (in-
stead of consensus AG) at the 39-splice site (Fig. 2B). A GT
consensus dinucleotide was present 1 bp upstream of the pre-
dicted 59-splice site in intron I, while another consensus dinu-
cleotide, AG, was located at the beginning of the coding region
of exon II, 2 bp downstream of the expected splice site (Fig. 2B).
If these consensus sequences were the actual splice junctions,
the resulting DNA equivalent of the Ntan1 mRNA sequence in
this region would have been CTGGAAAGA rather than CTG-
GAGGAAAGA actually present in the clonedNtan1 cDNA. The
latter sequence occurred not only in the Ntan1 cDNA derived
from a MEL cell cDNA library, but also in the products of
reverse transcription-PCR (see “Experimental Procedures”)
carried out using MEL cell mRNA and two independent sets of
primers (data not shown). Moreover, the homologous region of
porcine cDNA also contained “nonconsensus” splice junctions
(40). We conclude that the usually strict constraints on the
sequences of splice sites (61, 62) are bypassed at the sites that
define intron V and especially intron I of the mouse Ntan1
gene.
The Ntan1 Promoter—To identify the promoter of mouse
Ntan1, we first analyzed a region immediately upstream of
exon I within the ;1.7-kb genomic BamHI fragment (Figs. 2B
and 3). Nucleotide sequencing indicated the presence of multi-
ple binding sites for the transcription factor Sp1 (63) immedi-
ately upstream of the Ntan1 ATG start codon. This area (Fig.
2B) resembled the GC-rich promoter regions of several weakly
transcribed housekeeping genes (64); the similarities included
the absence of TATA and CCAAT consensus sequences charac-
teristic of many other eukaryotic promoters. However, given
the ;1.4-kb size of Ntan1 mRNA (see below), the distance
between the Ntan1 start codon and the poly(A) addition site
(1068 bp), and the presumed size of the poly(A) tail (100–200
nucleotides), the Ntan1 promoter was expected to be present
;200 bp upstream of the start codon. The mapping of Ntan1
FIG. 1. Comparison of enzymatic reactions that underlie the
activity of N-dt and N-ds residues in the N-end rule pathways of
different organisms. A, mammalian cells: rabbit reticulocytes and
mouse (M. musculus) L-cells (7, 8). B, the yeast S. cerevisiae (6). C, the
eubacterium E. coli (5). The E. coli N-end rule lacks N-dt residues. The
postulated mammalian NtQ-amidase (a question mark in A) remains to
be identified. It is also unknown whether an N-terminal Cys residue is
arginylated by the same species of mammalian R-transferase that argi-
nylates N-terminal Asp or Glu or whether a Cys-specific R-transferase
is involved. A question mark adjacent to the Ser residue in A refers to
the fact that Ser is a destabilizing residue in reticulocyte extract (7), but
a stabilizing residue in fibroblast-like mouse L-cells in vivo (8). L/F-
transferase, Leu/Phe-tRNA-protein transferase.
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mRNA by primer extension (see below) also failed to indicate
the presence of Ntan1 mRNAs whose 59-ends were located
within 100 bp of the Ntan1 start codon.
Nucleotide sequencing revealed a putative TATA box consen-
sus sequence 510 bp upstream of the Ntan1 start codon. A
CCAAT consensus sequence was present 45 bp upstream of this
TATA box (Fig. 2B). In a typical TATA/CCAAT-containing eu-
karyotic promoter, transcription starts 16–35 bp downstream
of TATA (65, 66). Indeed, a primer extension analysis, using
Ntan1 mRNA as a template and a synthetic oligonucleotide
primer matching the 39-end of the sequence of exon I, mapped
a set of major 59-ends of Ntan1mRNA to the region ;18 to ;32
bp downstream of the above TATA box, with the 59-ends at
positions 959 and 960 (Fig. 2B) being the most frequent ones
(data not shown). On the assumption that the 59-ends of Ntan1
mRNA defined by primer extension were the actual transcrip-
tion start sites (rather than sites resulting from a 59-processing
of initial transcription products), these data indicated that the
synthesis of Ntan1 pre-mRNA begins ;480 bp upstream of the
Ntan1 start codon. Two other TATA box consensus sequences
FIG. 2. A, the deduced amino acid sequence of mouse NtN-amidase (NTAN1). The directly determined sequences of two peptides produced from
porcine NtN-amidase (40) are shown above the corresponding regions of mouse NtN-amidase; divergent residues are doubly underlined. B,
nucleotide sequence of the mouse Ntan1 gene upstream of its start codon, nucleotide sequences (and the corresponding amino acid sequences) of
Ntan1 exons, and the adjacent intron sequences. The putative promoter consensus elements CCAAT and TATAA are doubly underlined. A 208-bp
region that encompasses a 39-region of the Ntan1 ORF and that is 98.6% identical to a 39-flanking untranslated region of the mouse Il2 gene (see
“Results”) is singly underlined. A double arrow indicates the location of the poly(A) addition site in the Ntan1 cDNA (data not shown). A sequence
matching the consensus sequence that precedes poly(A) addition sites in mammalian genes is doubly underlined. Most (.75%) of the ;17-kbNtan1
locus was sequenced on both strands. Nucleotide sequences reported in this paper have been submitted to the GenBankTM/EMBL Data Bank with
accession numbers U57691 (mouse Ntan1 genomic DNA) and U57692 (mouse Ntan1 cDNA).
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were present in the genomic DNA upstream of the sites corre-
sponding to the mapped 59-ends ofNtan1mRNAs (Fig. 2B), but
these putative TATA boxes were not accompanied by CCAAT
boxes.
The ;480-bp distance between Ntan1 transcription start
sites and the Ntan1 start codon predicts the Ntan1 mRNA size
of 1.7 kb (assuming the mean length of the Ntan1 mRNA
poly(A) tail to be 0.15 kb), which is larger than the apparent
size ofNtan1mRNA in the Northern experiments (;1.4 kb; see
below). This discrepancy may be due to an anomalous electro-
phoretic mobility of Ntan1 mRNA, to its cleavage during isola-
tion, or, less likely, to the presence of an untranslated intron in
the 59-region of Ntan1 pre-mRNA (no evidence for such an
intron has been found).
In addition to the TATA and CCAAT sequences, the appar-
ent promoter region ;0.5 kb upstream of theNtan1 start codon
(Fig. 2B) contains putative binding sites for “general” tran-
scription factors such as CP-1, AP-1, E2A, ATF, and NF-I (63,
67, 68) as well as putative sites for other transcription factors
such as c/EBP, AP-2, HNF-1, SDR, PEA3, Ets1, H-2DIIBP,
NFuE1, NFuE2, PU.1, and HC3 (67, 69–79). The roles, if any,
of these transcription factors in the expression ofNtan1 remain
to determined.
Chromosome Mapping of Ntan1—The chromosomal location
of Ntan1 was determined by interspecific backcross analysis
using DNA of progeny derived from matings of ((C57BL/6J 3
M. spretus)F1 3 C57BL/6J) mice. This interspecific backcross
mapping panel has been typed over 2000 loci distributed
among all of the mouse 19 autosomes as well as the X chromo-
some (53). C57BL/6J and M. spretus DNAs were digested with
several restriction endonucleases and analyzed by Southern
hybridization for informative restriction fragment length poly-
morphisms using a mouse Ntan1 genomic probe. The ;4-kb
HindIII M. spretus-specific restriction fragment length poly-
morphism (see “Experimental Procedures”) was used to follow
the segregation of Ntan1 in backcross mice. The results of this
mapping indicated that Ntan1 is located in the proximal region
of mouse chromosome 16 and is linked to Prm1, Cebpd, and Igl
(see “Experimental Procedures”) (Fig. 4). Although 160 mice
were analyzed for every marker to produce the segregation
analysis data in Fig. 4, up to 185 mice were typed for some
pairs of markers. Each locus was analyzed in pairwise combi-
nations for recombination frequencies using these additional
data. The ratios of the total number of mice exhibiting recom-
binant chromosomes to the total number of mice analyzed for
each pair of loci and the most likely gene order were as follows:
centromere-Prm1-(4:168)-Ntan1-(1:166)-Cebpd-(1:185)-Igl.
The recombination frequencies (expressed as genetic distances
in centimorgans 6 S.E.) were as follows: Prm1-(2.4 6 1.2)-
Ntan1-(0.6 6 0.6)-Cebpd-(0.5 6 0.5)-Igl.
We have compared our interspecific map of chromosome 16
with a composite mouse linkage map that reports the map
location of many uncloned mouse mutations (the mouse ge-
nome data base at the Jackson Laboratory, Bar Harbor, ME).
Ntan1 is located in a region of the composite map that is
FIG. 3. The mouse Ntan1 gene. The horizontal line represents genomic DNA, and the rectangles denote exons. The sizes of exons and introns
are indicated. An arrow upstream of exon I indicates the position of the Ntan1 transcription start site, ;500 bp from the Ntan1 start codon, as
determined by the primer extension technique. BamHI (B) and EcoRI (R) restriction sites are also indicated. See Fig. 2B for the putative promoter
consensus elements and “Results” for a partial list of putative binding sites for transcription factors.
FIG. 4. Ntan1 is located in the proximal region of mouse chro-
mosome 16. The chromosomal position of Ntan1 was determined using
interspecific backcross analysis (see “Experimental Procedures”). The
segregation patterns of Ntan1 and flanking loci in 160 backcross ani-
mals that were typed for all loci are shown at the top. For individual
pairs of loci, .160 animals were typed (see “Results”). Each column
represents the chromosome identified in the backcross progeny that
was inherited from the (C57BL/6J 3 M. spretus)F1 parent. The filled
boxes denote the presence of a C57BL/6J allele. The unfilled boxes
denote the presence of a M. spretus allele. The number of offspring
inheriting each type of chromosome is listed at the bottom of each
column. A partial chromosome 16 linkage map, showing the location of
Ntan1 in relation to linked genes, is shown at the bottom. Recombina-
tion distances between loci (in centimorgans) are shown to the left of the
chromosome. The positions of homologous loci in human chromosomes,
where known, are shown on the right. References for the human map
positions of loci cited here can be obtained from Genome Data Base, a
computerized data base of human linkage information maintained by
the William H. Welch Medical Library of the Johns Hopkins University
(Baltimore, MD).
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relatively devoid of uncloned mouse mutations (data not
shown). The proximal region of mouse chromosome 16 shares
regions of homology with human chromosomes 16p, 8q, and 22q
(summarized in Fig. 4) (80). Indeed, recent analyses, using
fluorescent in situ hybridization and phage P1 clones contain-
ing humanNTAN1 genomic DNA, localized the humanNTAN1
gene to chromosome 16p (a region of homology to the chromo-
somal location of mouse Ntan1).7
Differential Regulation of mRNAs Encoding NTAN1 and a
Specific E2 Enzyme—Northern hybridization was used to com-
pare the levels of Ntan1 mRNA among mouse tissues and cell
lines. In addition to anNtan1-specific probe, these comparisons
included a probe for E214K, a mouse E2 enzyme whose sequence
is similar to that of S. cerevisiae Ubc2p. The latter E2 enzyme
(one of at least 11 distinct E2 enzymes in S. cerevisiae) is a
component of the yeast N-end rule pathway (31, 32). We em-
ployed the rabbit E214K cDNA (52) to isolate a mouse cDNA
that encodes E214K (see “Experimental Procedures”). This
cDNA was used as a probe in the Northern hybridizations
(Fig. 5, B and D). The control probes in these analyses were
cDNAs encoding mouse b-actin and GAPDH (see “Experi-
mental Procedures”) (57). The level of Ntan1 mRNA in mouse
tissues was ;100-fold lower than the level of b-actin mRNA
(data not shown).
A Northern blot containing approximately equal amounts of
poly(A)1 RNA from various mouse tissues was hybridized with
Ntan1 cDNA. This probe detected a diffuse ;1.4-kb band
whose relative abundance (quantified using a PhosphorIm-
ager) varied at most 2-fold among different tissues (Fig. 5A).
The testis-derived Ntan1 mRNA existed as two species: the
minor one comigrated with the ;1.4-kb Ntan1 mRNA of the
other tissues, while the major one had the apparent size of ;1.1
kb (Fig. 5A). It is unknown whether the testis-specific Ntan1
Northern pattern was entirely the result of RNA degradation
during isolation. The two species of E214K mRNA (Fig. 5B) were
apparently derived from two distinct primary transcripts (see
“Experimental Procedures”). In contrast to the relative con-
stancy of Ntan1 mRNA levels among different tissues, the
levels of E214K mRNA varied significantly, with the highest
expression in skeletal muscle (Fig. 5, A and B). Consistent with
this observation was the presence of several putative binding
sites for MyoD, a muscle-specific transcription factor (81), in a
region upstream of the start codon of the rat E214K ORF (Gen-
BankTM/EMBL accession number U04303) (data not shown);
no putative MyoD-binding sites were detected in the Ntan1
promoter.
A Northern analysis of Ntan1 and E214K mRNAs was also
carried out with poly(A)1 RNA prepared from Friend erythro-
leukemia (MEL-C19) and myoblast (C2C12) cell lines (Fig. 5, C
and D). The relative amount of Ntan1 mRNA in MEL and
C2C12 cells before differentiation was ;3- and ;20-fold higher,
respectively, than the amount of Ntan1 mRNA in skeletal
muscle (Fig. 5 and data not shown). Poly(A)1 RNA was also
isolated from MEL cells that were induced to differentiate
under conditions that resulted in 95% of the cells ceasing
growth and producing hemoglobin (see “Experimental Proce-
dures”). The relative levels of Ntan1 mRNA were approxi-
mately the same in the growing, undifferentiated MEL cells
and in their differentiated counterparts (Fig. 5C). Similar re-
sults were obtained with the mouse lymphoma EL4 cells that
have been induced by a phorbol ester to differentiate and ex-
press interleukin-2 (data not shown). By contrast, the conver-
sion of C2C12 myoblasts (which contained the highest levels of
Ntan1 mRNA among the mouse tissues and cell lines exam-
ined) into myotubes (see “Experimental Procedures”) was ac-
companied by an ;4-fold decrease in the level of Ntan1mRNA,
whose relative amount in myotubes was slightly higher than in
MEL cells, but significantly higher than in skeletal muscle
(Fig. 5B).
Mouse NTAN1 Is an N-terminal Asparagine-specific Ami-
dase—The 88% similarity between the sequences of porcine
NtN-amidase (40) and the mouse NTAN1 protein (Fig. 2A)
strongly suggested that NTAN1 is also an NtN-amidase. To
verify this conjecture, we asked whether extracts prepared
from S. cerevisiae nta1D cells that lacked the endogenous yeast
Nt-amidase (encoded by NTA1 (27)) but expressed mouse
NTAN1 possess the expected NtN-amidase activity. The ami-
dase assay employed 35S-labeled derivatives of mouse DHFR
that bore different N-terminal residues (see “Experimental
Procedures”). A 35S-X-DHFR (X 5 Asn, Gln, or Asp) was incu-
bated in an S. cerevisiae extract and subjected to IEF on a
urea-containing polyacrylamide gel. This procedure fraction-
ates a protein according to its pI (82). Since deamidation of Asn
or Gln converts a neutral side chain into a negatively charged
one, this modification should be detectable through a distinct
shift in pI. Indeed, while the pI positions of Asn-DHFR and
Gln-DHFR were indistinguishable, the pI position of otherwise
identical Asp-DHFR that bore N-terminal Asp was shifted to-
ward a lower pI (Fig. 6, lanes j–m; and data not shown).
The pI of 35S-Asn-DHFR was not altered after its incubation
with an extract from S. cerevisiae nta1D that lacked the NTA1-
encoded yeast Nt-amidase (Fig. 6, lanes j andm). However, the
incubation of 35S-Asn-DHFR with an extract from otherwise
identical nta1D cells that expressed mouse NTAN1 resulted in
a pI shift of the DHFR substrate (Fig. 6, lanes g–i and p). In
contrast to the yeast NTA1-encoded Nt-amidase, which deami-
dated either Asn-DHFR or (more slowly) Gln-DHFR (Fig. 6,
lanes a–f and n–o), no deamidation of Gln-DHFR was observed
with S. cerevisiae nta1D extracts containing mouse NTAN1
(Fig. 6, lane q), strongly suggesting that NTAN1 is specific for
N-terminal Asn (see below for independent in vivo evidence
bearing on this conclusion). In addition, the absence of charge
modifications in the case of Gln-DHFR (but not in the case of
7 U. Bengtsson, A. E. Stewart, R. A. Bradshaw, and S. M. Arfin,
manuscript in preparation.
FIG. 5.Ntan1 and E214K mRNAs in mouse tissues and cell lines.
Shown is the Northern hybridization analysis of RNA from the indi-
cated tissues and cell lines, using DNA probes specific for Ntan1mRNA
(A and C) and E214K mRNA (B and D) (see “Experimental Procedures”).
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Asn-DHFR) that has been incubated with NTAN1 (Fig. 6, lanes
p and q) strongly suggested that the activity of NTAN1 is
confined to N-terminal residues (no deamidation of internal
Asn or Gln in Gln-DHFR). These findings confirmed and ex-
tended the observations made by Stewart et al. (39) with por-
cine NtN-amidase, using peptide-size amidase substrates and
high pressure liquid chromatography fractionation of reaction
products.
Mouse NtN-amidase Can Implement the Asparagine-specific
Subset of the Yeast N-end Rule—We asked whether the mouse
Ntan1-encoded NtN-amidase (NTAN1) could function in the
yeast N-end rule pathway. In particular, we wished to deter-
mine whether the confinement of the in vitro deamidating
activity of mouse NtN-amidase (Fig. 7) to N-terminal Asn is
retained under in vivo conditions. The test proteins were de-
rivatives of E. coli bgal. In eukaryotes, Ub fusions such as
Ub-X-bgal (X 5 a residue at the Ub-bgal junction) are rapidly
deubiquitylated by Ub-specific proteases to yield X-bgal test
proteins (2). In contrast to the function of Ub in protein degra-
dation, the role of Ub in these engineered Ub fusions is to allow
the in vivo generation of otherwise identical proteins bearing
different N-terminal residues. Metabolic stabilities of X-bgal
proteins could be compared either indirectly (by determining
the intracellular concentrations of X-bgal proteins) (Fig. 7) or
directly (in pulse-chase experiments) (Fig. 8). Previous work
(27–32) has shown that the enzymatic activity of an X-bgal
protein in yeast cells is a sensitive indicator of its metabolic
stability.
An nta1D strain of S. cerevisiae that lacked the yeast NTA1-
encoded Nt-amidase and expressed specific X-bgal (Ub-X-bgal)
proteins such as Met-bgal, Asp-bgal, Asn-bgal, or Gln-bgal was
transformed with plasmids expressing either S. cerevisiae
Nta1p or mouse NTAN1, and the relative metabolic stabilities
of X-bgal test proteins were determined for each transformant
by measuring the activity of bgal (Fig. 7). In wild-type (NTA1)
S. cerevisiae, the level of Met-bgal (t1⁄2 . 20 h (6)) was much
higher than the levels of Asp-bgal, Asn-bgal, and Gln-bgal (t1⁄2
5 ;3, ;3, and ;10 min, respectively (6)), with the level of
Gln-bgal being slightly higher than the levels of the two other
normally short-lived X-bgal proteins (Fig. 7). The same meas-
urements in congenic nta1D cells showed that the level of
Asp-bgal (bearing a secondary destabilizing N-terminal resi-
due) remained unchanged (in comparison to NTA1 cells),
whereas the levels of Asn-bgal and Gln-bgal (bearing the ter-
tiary destabilizing N-terminal residues) became nearly equal to
the level of the long-lived Met-bgal (Fig. 7; see also Ref. 6).
As expected, the expression of a plasmid-borne S. cerevisiae
NTA1 gene in nta1D cells restored the low levels of Asn-bgal
and Gln-bgal without altering the levels of Met-bgal or Asp-
bgal (Fig. 7). However, the expression of NTAN1 in S. cerevi-
siae nta1D resulted in low levels of Asn-bgal, but did not restore
the low levels of Gln-bgal, in contrast to the effect of the yeast
Nta1p Nt-amidase (Fig. 7). These findings were confirmed by
pulse-chase analyses of Asn-bgal, Gln-bgal, and Arg-bgal deg-
radation in yeast nta1D cells transformed with a plasmid ex-
pressing mouse NTAN1 (Fig. 8). We conclude that the in vitro
selectivity of mouse NtN-amidase for N-terminal Asn was re-
tained in vivo.
Although Nt-amidase activity (with Asn-DHFR as a sub-
strate) in extracts from S. cerevisiae nta1D that expressed
NTAN1 was significantly higher than the same activity in
extracts from wild-type (Nta1p-containing) S. cerevisiae (data
not shown), Asn-bgal was more unstable in wild-type yeast
than in congenic cells that lacked Nta1p and expressed mouse
NTAN1 (Fig. 7). The apparently lower in vivo efficiency of the
mouse NtN-amidase (in comparison to the yeast Nta1p Nt-
amidase) in conferring a short half-life on a test protein such as
Asn-bgal may be caused by the likely absence of specific inter-
actions between the mouse NtN-amidase and the targeting
complex of the S. cerevisiae N-end rule pathway.
DISCUSSION
Stewart et al. (39, 40) reported the purification of a porcine
NtN-amidase and the cloning of its ;1.3-kb cDNA. Described in
the present paper is a further study of this enzyme, carried out
with its mouse counterpart. We report the following results.
1) The mouse Ntan1 gene spans ;17 kb of genomic DNA and
contains 10 exons ranging from 54 to 177 bp in length. The
;1.4-kb Ntan1 mRNA encodes a 310-residue (35 kDa) protein,
NTAN1 or NtN-amidase.
2) The mapping of Ntan1, carried out using interspecific
backcross analysis, located it in the proximal region of mouse
chromosome 16, in an area devoid of uncloned mouse mutations.
3) The deduced amino acid sequence of mouse NtN-amidase
lacks motifs that resemble membrane-spanning regions, signal
sequences, or nuclear localization signals. The sequence of
mouse NtN-amidase is 88 and 92% identical to the deduced
sequences of porcine and human NtN-amidases, respectively.
However, there are no significant sequence similarities be-
tween NtN-amidases and other known amidotransferases, in-
cluding the NTA1-encoded Nt-amidase of the yeast S. cerevi-
siae. The 52-kDa Nta1p protein, a component of the S.
cerevisiae N-end rule pathway, can deamidate N-terminal Asn
or Gln (27), whereas the 35-kDa mammalian NtN-amidase can
deamidate N-terminal Asn but not Gln (Fig. 1) (39).
4) The putative promoter region of Ntan1 is located ;500 bp
upstream of theNtan1 start codon. In addition to the TATA box
and CCAAT consensus sequences, this region contains putative
FIG. 6. Purified, 35S-labeled X-DHFR
test proteins bearing either Asn, Gln,
or Asp at their N termini were incu-
bated with the indicated extract
from S. cerevisiae and thereafter
fractionated by IEF (see “Experimen-
tal Procedures”). The control extract
was prepared from S. cerevisiae nta1D.
This extract was tested directly (“nta1D”)
or mixed with extracts prepared from oth-
erwise identical nta1D strains that also
carried plasmids expressing either S. cer-
evisiae NTA1 (“y. NTA1”) or mouse Ntan1
(“m. Ntan1”). Percent values shown refer
to the relative content of a given extract
in a total sample, the rest of it being the
extract from S. cerevisiae nta1D. The IEF
positions of X-DHFR proteins bearing N-
terminal Asp or Glu versus Asn or Gln are
shown on the left.
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binding sites for many of the known transcription factors, in-
cluding CP-1, AP-1, AP-2, E2A, c/EBP, SDR, PEA3, NFuE1,
NFuE2, HNF-1, Ets1, H-2DIIBP, PU.1, and HC3.
5) Northern analyses of the ;1.4-kb Ntan1 mRNA showed it
to be present in roughly equal amounts in all of the mouse
tissues examined, including skeletal muscle, brain, and liver.
The examined mouse cell lines expressed Ntan1 more strongly
than did mouse tissues. While the in vitro differentiation of
either Friend or lymphoma cells did not lead to a significant
alteration in the amount ofNtan1mRNA, its level was found to
be decreased ;4-fold upon the conversion of C2C12 myoblasts
into myotubes.
6) An isoelectric focusing assay was used to compare the in
vitro enzymatic specificities of the mouse NtN-amidase and the
yeast Nt-amidase. These experiments, using 35S-X-DHFR test
proteins and extracts from S. cerevisiae nta1D that either
lacked or expressed mouse NtN-amidase, have shown that NtN-
amidase deamidates N-terminal Asn but not Gln.
7) The expression of mouse NTAN1 in S. cerevisiae nta1D
was found to restore the degradation of Asn-bgal but not Gln-
bgal, indicating that mouse NtN-amidase can implement the
Asn-specific subset of the yeast N-end rule and also showing
that the in vitro selectivity of this enzyme for N-terminal Asn is
retained in vivo.
The hierarchic structure of the N-end rule “disperses” the
domains that recognize specific destabilizing N-terminal resi-
dues among several proteins such as Nt-amidase, R-transfer-
ase, and N-recognin (see the Introduction and Fig. 1). The
regulatory possibilities of this arrangement are apparent, but
physiological substrates of Nt-amidase and R-transferase re-
main unknown in both fungi and metazoans. Part of the diffi-
culty in identifying these substrates stems from the fact that
although a number of apparently cytosolic or nuclear proteins
bear, at least initially, the N-terminal sequence Met-Asn or
Met-Gln (39), the known Met-aminopeptidases are incapable of
removing N-terminal Met if it is followed by an Asn or a Gln
residue (4). In addition, at least the Met-Asn sequence is often
acetylated at the N-terminal Met residue (83). It is unknown
whether any of the resulting Ac-Met-Asn-containing N-termi-
nal regions are processed in vivo to yield N-terminal Asn.
Recently, certain sequences bearing N-terminal Met-Gln have
been found to yield N-terminal Gln in vivo (84). The corre-
sponding processing protease(s) remains to be identified. The
isolation of Ntan1 and the resulting possibility of producing
mouse ntan1D cells through targeted mutagenesis may provide
additional routes to physiological substrates of NtN-amidase,
for instance, through a search for proteins whose metabolic
stabilities (or isoelectric points) differ between Ntan1 and
ntan1D cells.
The possibility that certain cell types in a multicellular or-
ganism may lack NtN-amidase, yielding, in these cells, an N-
end rule pathway that spares normally short-lived proteins
bearing N-terminal Asn, has been made less likely by the
finding that Ntan1 is expressed in all of the mouse tissues and
cell lines examined. However, the Northern-based Ntan1 ex-
pression assays used thus far (Fig. 5) have been crude, their
results being still compatible with the possibility of strong local
differences in the levels of Ntan1 expression within specific
tissues. Furthermore, if a binding site for NtN-amidase in a
targeting complex of the mammalian N-end rule pathway over-
laps with a binding site for the postulated NtQ-amidase, the
competition between these enzymes for binding to the targeting
complex and the likely presence of substrate channeling in the
N-end rule pathway (27) may strongly influence the degrada-
tion of N-end rule substrates bearing N-terminal Asn versus
those bearing N-terminal Gln. This hypothesis may account for
the paradoxically slow degradation of Gln-bgal (but not Asn-
bgal) in C2C12 myoblasts, which exhibited the highest level of
Ntan1 mRNA among the tested mouse tissues and cell lines,
but contained the postulated NtQ-amidase as well, as indicated
by in vitro deamidation tests with extracts from C2C12 cells.
5
The apparent absence of Ntan1 homologs in the mouse ge-
nome (those that can be detected by a low-stringency Southern
hybridization) (data not shown) suggests that the postulated
NtQ-amidase might be encoded by a differentially spliced
mRNA derived from the Ntan1 gene. Indeed, although no dif-
ferential splicing of mouse Ntan1 pre-mRNA has been detected
thus far, the GenBankTM/EMBL Data Bank was found to con-
tain partial nucleotide sequences of apparent human NTAN1
cDNAs (accession numbers H27710, H28425, R10897, N98532,
H44229, N93132, N80205, and N69930), one of which
(H28425), but not the others, lacks exon II of Ntan1 (data not
shown). In addition, intron I (Figs. 2B and 3), which abuts exon
II, contains noncanonical dinucleotide sequences at both 59-
and 39-splice sites (see “Results”). This circumstantial evidence
for the hypothesis of a single gene encoding both NtN-amidase
and NtQ-amidase remains to be verified directly.
The hierarchic organization of N-end rules, with their terti-
ary, secondary, and primary destabilizing residues (N-dt, N-ds,
and N-dp, respectively), is a feature that is more conserved in
evolution than the Ub dependence of an N-end rule pathway or
FIG. 7.Mouse NtN-amidase can implement the asparagine-spe-
cific subset of the yeast N-end rule. A, levels of bgal activity in
wild-type (NTA1) S. cerevisiae (strain YPH500) expressing X-bgal (Ub-
X-bgal) test proteins, where X 5 Met (M), Asp (D), Asn (N), or Gln (Q)
(see “Experimental Procedures”). B, same as A, but in a congenic nta1D
strain. C, same as B, but nta1D cells carried a high-copy plasmid
expressing the yeast NTA1 gene from the PADH1 promoter in pRB201
(27). D, same as B, but nta1D cells carried a high-copy plasmid express-
ing the mouse Ntan1 cDNA from the PGAL1 promoter in pSG61 (see
“Experimental Procedures”). Values shown are the means from dupli-
cate measurements, which yielded results within 15% of each other.
The absolute levels of Met-bgal activity in different S. cerevisiae strains
were within 20% of each other (data not shown).
FIG. 8. Metabolic stabilities of Gln-bgal, Asn-bgal, and Arg-
bgal in S. cerevisiae nta1D that expressed mouse NtN-amidase.
Cells were labeled with [35S]methionine/cysteine for 5 min, followed by
a chase for 0, 20, and 60 min in the presence of cycloheximide; prepa-
ration of extracts; immunoprecipitation of X-bgal; and SDS-polyacryl-
amide gel electrophoresis (see “Experimental Procedures”).
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the identity of enzymatic reactions that mediate the hierarchy
of destabilizing residues (4). For example, in a bacterium such
as E. coli, which lacks the Ub system, the N-end rule has both
N-ds and N-dp residues (it lacks N-dt residues) (Fig. 1) (5, 85).
The identities of N-ds residues in E. coli (Arg and Lys) are
different from those in eukaryotes (Asp and Glu in yeast; Asp,
Glu, and Cys in mammals). Bacterial and eukaryotic enzymes
that implement the coupling between N-ds and N-dp residues
are also different: Leu/Phe-tRNA-protein transferase in E. coli
and R-transferase in eukaryotes. Note, however, that bacterial
Leu/Phe-tRNA-protein transferase and eukaryotic R-transfer-
ase catalyze reactions of the same type (conjugation of an
amino acid to an N-terminal residue of a polypeptide) and use
the same source of activated amino acid (aminoacyl-tRNA)
(Fig. 1).
The apparent confinement of R-transferase to eukaryotes
and of Leu/Phe-tRNA-protein transferase to prokaryotes (Fig.
1) suggests that secondary destabilizing residues were re-
cruited late in the evolution of the N-end rule, after the diver-
gence of prokaryotic and eukaryotic lineages. The lack of se-
quence similarity between the yeast Nt-amidase and the
mammalian NtN-amidase and the more narrow specificity of
the mammalian enzyme (Fig. 1) suggest that tertiary destabi-
lizing residues (Asn and Gln) became a part of the N-end rule
pathway much later yet, possibly after the divergence of meta-
zoan and fungal lineages. If so, the N-end rule pathway may be
an especially informative witness of evolution: the ancient or-
igins of this proteolytic system, the simplicity and discreteness
of changes in the rule books of N-end rules among different
species, and the diversity of proteins that either produce or
target the N-degron should facilitate phylogenetic deductions
once the components of this pathway become characterized
across a broad range of organisms.
Although the properties of the Ntan1-encoded mouse NtN-
amidase are fully consistent with its being a component of the
mouse N-end rule pathway and although mouse NtN-amidase
was shown to be capable of implementing the Asn-specific
subset of the yeast N-end rule in vivo, a rigorous test of the
presumed function of this enzyme requires the production of
mouse cell lines and/or whole animals that lackNtan1. Work in
this direction is under way.
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